PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

Recruiting now · Not applicable

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

Key facts

Study ID

NCT05306743

Run by

Observational and Pragmatic Research Institute

People needed

126

Starts

2022-09-23

Expected to finish

2026-12-01

Last updated by the study team

2023-10-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary Care Teams (PCTs) must be able to function as a single randomization unit with low risk of contamination between participants and physicians due to the absence of blinding in the intervention (see section 8.8 for details on blinding).
• PCT must have a sufficient number of patients meeting modifiable high-risk patient criteria (see section 8.1 on sample size estimates).
• PCT must express willingness to be randomized to either receive the CONQUEST program initially, or usual care until program roll-out to the delayed intervention arm.

You may not qualify if…

• PCTs that are in the process of, or planning to change EHR software provider or practice ownership within the trial outcome evaluation period
• PCTs engaged in active research studies or COPD related Quality Improvement Programs which might impact the ability to implement CONQUEST program.

Where it is running

• University of Colorado — Denver, Colorado, United States (enrolling)
• Mount Sinai — New York, New York, United States (enrolling)
• MetroHealth — Cleveland, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.